Herpes Simplex Oncolytic Viral Therapy for Malignant Glioma and Mechanisms of Delivery

被引：0
|
作者：
Erickson, Nicholas J. [1 ]
Stavarache, Mihaela [2 ]
Tekedereli, Ibrahim [1 ]
Kaplitt, Michael G. [2 ]
Markert, James M. [1 ]
机构：
[1] Univ Alabama Birmingham, Dept Neurosurg, Birmingham, AL 35294 USA
[2] Weill Cornell Med, Dept Neurol Surg, Lab Mol Neurosurg, New York, NY USA
来源：
WORLD NEUROSURGERY | 2025年 / 194卷
关键词：
Magnetic resonance-guided focused ultrasound; Magnetic Malignant glioma; Oncolytic viral therapy; INTENSITY FOCUSED ULTRASOUND; BRAIN-BARRIER DISRUPTION; LIPOSOMAL DOXORUBICIN; RIBONUCLEOTIDE REDUCTASE; GLIOBLASTOMA-MULTIFORME; ENHANCED DELIVERY; TUMOR BARRIER; VIRUS; REPLICATION; VIROTHERAPY;
D O I：
10.1016/j.wneu.2024.123595
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
The authors present a comprehensive review on the history and development of oncolytic herpes simplex viral therapies for malignant glioma with a focus on mechanisms of delivery in prior and ongoing clinical trials. This review highlights the advancements made with regard to delivering these therapies to a highly complex immunologic environment in the setting of the blood-brain and blood-tumor barrier in a safe and effective manner.
引用
收藏
页数：9
相关论文
共 50 条
  • [1] Oncolytic Viral Therapy of Malignant Glioma
    Parker, Jacqueline Nuss
    Bauer, David F.
    Cody, James J.
    Marker, James M.
    NEUROTHERAPEUTICS, 2009, 6 (03) : 558 - 569
  • [2] Oncolytic viral therapy of malignant glioma
    Jacqueline Nuss Parker
    David F. Bauer
    James J. Cody
    James M. Markert
    Neurotherapeutics, 2009, 6 : 558 - 569
  • [3] Oncolytic herpes simplex virus therapy for malignant glioma: current approaches to successful clinical application
    Hua, Lingyang
    Wakimoto, Hiroaki
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2019, 19 (08) : 845 - 854
  • [4] Advances in oncolytic herpes simplex virus and adenovirus therapy for recurrent glioma
    Hu, Mingming
    Liao, Xuliang
    Tao, Yi
    Chen, Yaohui
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [5] Oncolytic Viral Therapy for Malignant Glioma and Their Application in Clinical Practice
    Madison L. Shoaf
    Annick Desjardins
    Neurotherapeutics, 2022, 19 : 1818 - 1831
  • [6] Herpes simplex virus 1 as an oncolytic viral therapy for refractory cancers
    Scanlan, Hayle
    Coffman, Zachary
    Bettencourt, Jeffrey
    Shipley, Timothy
    Bramblett, Debra E.
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [7] Oncolytic Viral Therapy for Malignant Glioma and Their Application in Clinical Practice
    Shoaf, Madison L.
    Desjardins, Annick
    NEUROTHERAPEUTICS, 2022, 19 (06) : 1818 - 1831
  • [8] Oncolytic herpes simplex viral therapy effectively treats and improves survival in a murine model of pleural malignant mesothelioma
    Adusumilli, PS
    Stiles, BM
    Chan, MK
    Rusch, VW
    Fong, YM
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2004, 199 (03) : S30 - S31
  • [9] Oncolytic viral therapy for gliomas: Advances in the mechanisms and approaches to delivery
    Romanishin, A.
    Vasilev, A.
    Khasanshin, E.
    Evtekhov, A.
    Pusynin, E.
    Rubina, K.
    Kakotkin, V.
    Agapov, M.
    Semina, E.
    VIROLOGY, 2024, 593
  • [10] Implications of immune cells in oncolytic herpes simplex virotherapy for glioma
    Otani, Yoshihiro
    Yoo, Ji Young
    Shimizu, Toshihiko
    Kurozumi, Kazuhiko
    Date, Isao
    Kaur, Balveen
    BRAIN TUMOR PATHOLOGY, 2022, 39 (02) : 57 - 64
12345